Fragment-based lead discovery: challenges and opportunities

被引：17
|
作者：
Sun, Chaohong [1 ]
Petros, Andrew M. [1 ]
Hajduk, Philip J. [1 ]
机构：
[1] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | 2011年 / 25卷 / 07期
关键词：
Fragment-based drug design; Biologics; Off-shoring; Outsourcing; DRUG DISCOVERY; DESIGN; INHIBITORS; BIOLOGICS; BIG;
D O I：
10.1007/s10822-011-9451-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.
引用
收藏
页码：607 / 610
页数：4
相关论文
共 50 条
  • [1] Fragment-based lead discovery: challenges and opportunities
    Chaohong Sun
    Andrew M. Petros
    Philip J. Hajduk
    Journal of Computer-Aided Molecular Design, 2011, 25 : 607 - 610
  • [2] Fragment-based lead discovery
    David C. Rees
    Miles Congreve,
    Christopher W. Murray
    Robin Carr
    Nature Reviews Drug Discovery, 2004, 3 : 660 - 672
  • [3] Fragment-Based Lead Discovery
    Davis, Ben J.
    Roughley, Stephen D.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 371 - 439
  • [4] Challenges and opportunities for synthetic methodology in fragment-based drug discovery
    Day, James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [5] Fragment-Based Lead Discovery
    Congreve, Miles
    Murray, Christopher W.
    Carr, Robin
    Rees, David C.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 431 - 448
  • [6] Fragment-based lead discovery
    Rees, DC
    Congreve, M
    Murray, CW
    Carr, R
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 660 - 672
  • [7] Fragment-Based Lead Discovery and Design
    Joseph-McCarthy, Diane
    Campbell, Arthur J.
    Kern, Gunther
    Moustakas, Demetri
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (03) : 693 - 704
  • [8] EXPERIENCES IN FRAGMENT-BASED LEAD DISCOVERY
    Hubbard, Roderick E.
    Murray, James B.
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 509 - 531
  • [9] Fragment-based lead discovery grows up
    Monya Baker
    Nature Reviews Drug Discovery, 2013, 12 : 5 - 7
  • [10] A rule of three for fragment-based lead discovery?
    Congreve, M
    Carr, R
    Murray, C
    Jhoti, H
    DRUG DISCOVERY TODAY, 2003, 8 (19) : 876 - 877
12345